<DOC>
	<DOCNO>NCT02211170</DOCNO>
	<brief_summary>Study determine effect single dose BIRB 796 BS systemic inflammatory response induce endotoxin healthy human</brief_summary>
	<brief_title>Effect Single Oral Dose BIRB 796 BS Endotoxin-induced Inflammatory Responses Healthy Human Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male subject determine result screen Signed write informed consent accordance Good Clinical Practice local legislation Age ≥18 ≤ 35 year Broca ≥ 20 % ≤ + 20 % Able communicate well investigator comply study requirement Any find medical examination ( include blood pressure , pulse rate EKG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection within 14 day enrolment History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) ( &lt; 1 month prior administration trial ) Use drug , might influence result trial ( &lt; 10 day prior administration trial ) Participation another trial investigational drug ( &lt; 3 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation loss &gt; 400 ml ( &lt; 2 month prior administration trial ) Excessive physical activity ( &lt; 24 hour prior administration trial ) Any laboratory value outside reference range clinical relevance History familial bleeding disorder Weight &gt; 150 kg Prior confirm suspected receipt monoclonal antibody</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>